Amidst the backdrop of steady interest rates and a mixed economic outlook in Canada, investors are turning their attention to potential opportunities in the stock market. Penny stocks, though often associated with speculative trading, remain an intriguing area for those seeking growth potential within smaller or newer companies. When these stocks are supported by strong financials, they can offer unique chances for significant returns.
Top 10 Penny Stocks In Canada
| Name |
Share Price |
Market Cap |
Financial Health Rating |
| Cannara Biotech (TSX:LOVE) |
CA$1.78 |
CA$179.78M |
★★★★★★ |
| Zoomd Technologies (TSXV:ZOMD) |
CA$0.93 |
CA$95.25M |
★★★★★★ |
| Montero Mining and Exploration (TSXV:MON) |
CA$0.68 |
CA$5.68M |
★★★★★★ |
| CEMATRIX (TSX:CEMX) |
CA$0.54 |
CA$80.89M |
★★★★★★ |
| Monument Mining (TSXV:MMY) |
CA$0.85 |
CA$304.57M |
★★★★★★ |
| Covalon Technologies (TSXV:COV) |
CA$1.90 |
CA$53.86M |
★★★★★★ |
| Thor Explorations (TSXV:THX) |
CA$1.34 |
CA$916.54M |
★★★★★★ |
| Computer Modelling Group (TSX:CMG) |
CA$3.95 |
CA$321.22M |
★★★★★☆ |
| Pulse Seismic (TSX:PSD) |
CA$4.23 |
CA$213M |
★★★★★★ |
| Caldwell Partners International (TSX:CWL) |
CA$0.93 |
CA$27.14M |
★★★★★★ |
Click here to see the full list of 311 stocks from our TSX Penny Stocks screener.
Underneath we present a selection of stocks filtered out by our screen.
Microbix Biosystems
Simply Wall St Financial Health Rating:★★★★☆☆
Overview:Microbix Biosystems Inc. is a life science company that develops and commercializes proprietary biological and technological solutions for human health across North America, Europe, and internationally, with a market cap of CA$33.82 million.
Operations:The company's revenue from product sales totaled CA$16.74 million.
Market Cap:CA$33.82M
Microbix Biosystems, with a market cap of CA$33.82 million and revenue of CA$16.74 million, is focusing on innovative quality assessment products (QAPs) for diagnostic accuracy in molecular assays and reference materials like QUANTDx for assay validation. Recent presentations at key conferences highlight its efforts in supporting the development of new assays and ensuring high-quality diagnostics. Despite being unprofitable, Microbix has reduced losses over five years by 8.9% annually and maintains a strong balance sheet with short-term assets exceeding liabilities significantly. The seasoned management team adds stability as they navigate growth opportunities in the life sciences sector.
-
Dive into the specifics of Microbix Biosystems here with our thorough balance sheet health report.
-
Gain insights into Microbix Biosystems' future direction by reviewing our growth report.
Colonial Coal International
Simply Wall St Financial Health Rating:★★★★★★
Overview:Colonial Coal International Corp. focuses on acquiring, exploring, and developing coal properties in Canada with a market cap of CA$438.65 million.
Operations:Colonial Coal International Corp. has not reported any revenue segments.
Market Cap:CA$438.65M
Colonial Coal International Corp., with a market cap of CA$438.65 million, is pre-revenue and focuses on coal property development in Canada. The company remains debt-free and has no long-term liabilities, providing a solid financial foundation despite being unprofitable with a negative return on equity of -18.73%. Its seasoned management team boasts an average tenure of 15.5 years, contributing to stability amid challenges like increasing losses over five years at 10% annually. Recent earnings reported a net loss reduction for six months ended January 31, 2026, indicating some improvement in managing its financial trajectory without significant shareholder dilution.
Kutcho Copper
Simply Wall St Financial Health Rating:★★★★★☆
Overview:Kutcho Copper Corp. focuses on acquiring and exploring resource properties in Canada, with a market cap of CA$69.21 million.
Operations:Kutcho Copper Corp. does not report any revenue segments.
Market Cap:CA$69.21M
Kutcho Copper Corp., with a market cap of CA$69.21 million, remains pre-revenue and unprofitable, yet it has made strides in reducing its debt to zero over the past five years. The company recently strengthened its board with experienced directors like Andrew Kaip and Jody Shimkus, enhancing its strategic oversight. Despite high share price volatility and negative return on equity, Kutcho Copper maintains a sufficient cash runway exceeding three years based on current free cash flow trends. The upcoming exploration program targeting high-grade copper-zinc deposits in British Columbia could potentially unlock significant value if successful.
Where To Now?
-
Reveal the 311 hidden gems among our TSX Penny Stocks screener with a single click here.
-
Contemplating Other Strategies? Uncover 15 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TSX:MBX TSXV:CAD and TSXV:KC.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
